These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 11146562
21. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease. Lee S, Cho BS, Kim SY, Choi SM, Lee DG, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Shin WS, Kim CC. Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971 [Abstract] [Full Text] [Related]
22. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience. Arellano ML, Langston A, Winton E, Flowers CR, Waller EK. Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760 [Abstract] [Full Text] [Related]
23. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of acute lymphoblastic leukemia in children. ASBMT Executive Committee. Biol Blood Marrow Transplant; 2006 Mar; 12(3):370-1. PubMed ID: 16503508 [No Abstract] [Full Text] [Related]
24. Allogeneic transplantation for childhood ALL. Mehta PA, Davies SM. Bone Marrow Transplant; 2008 Jan; 41(2):133-9. PubMed ID: 17994118 [Abstract] [Full Text] [Related]
27. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia. Vicent MG, Madero L, Ortega JJ, Martinez A, Gomez P, Verdeguer A, Badell I, Muñoz A, Olive T, Maldonado MS, Bureo E, Cubells J, Diaz MA, Spanish Working Party for BMT in Children (GETMON). Bone Marrow Transplant; 2002 Jul; 30(1):9-13. PubMed ID: 12105771 [Abstract] [Full Text] [Related]
29. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. Eapen M, Rubinstein P, Zhang MJ, Camitta BM, Stevens C, Cairo MS, Davies SM, Doyle JJ, Kurtzberg J, Pulsipher MA, Ortega JJ, Scaradavou A, Horowitz MM, Wagner JE. J Clin Oncol; 2006 Jan 01; 24(1):145-51. PubMed ID: 16382124 [Abstract] [Full Text] [Related]
30. Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group. Reismüller B, Attarbaschi A, Peters C, Dworzak MN, Pötschger U, Urban C, Fink FM, Meister B, Schmitt K, Dieckmann K, Henze G, Haas OA, Gadner H, Mann G, Austrian Berlin-Frankfurt-Münster (BFM) Study Group. Br J Haematol; 2009 Feb 01; 144(4):559-70. PubMed ID: 19077160 [Abstract] [Full Text] [Related]
31. Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study. Gutierrez-Aguirre CH, Gomez-Almaguer D, Cantu-Rodríguez OG, Gonzalez-Llano O, Jaime-Perez JC, Herena-Perez S, Manzano CA, Estrada-Gomez R, Gonzalez-Carrillo ML, Ruiz-Argüelles GJ. Bone Marrow Transplant; 2007 Sep 01; 40(6):535-9. PubMed ID: 17618317 [Abstract] [Full Text] [Related]
32. Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Parkman R, Cohen G, Carter SL, Weinberg KI, Masinsin B, Guinan E, Kurtzberg J, Wagner JE, Kernan NA. Biol Blood Marrow Transplant; 2006 Sep 01; 12(9):919-27. PubMed ID: 16920557 [Abstract] [Full Text] [Related]
33. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies. Small TN, Young JW, Castro-Malaspina H, Prockop S, Wilton A, Heller G, Boulad F, Chiu M, Hsu K, Jakubowski A, Kernan NA, Perales MA, O'Reilly RJ, Papadopoulos EB. Biol Blood Marrow Transplant; 2007 Feb 01; 13(2):235-44. PubMed ID: 17241929 [Abstract] [Full Text] [Related]
34. Utility of cranial boost in addition to total body irradiation in the treatment of high risk acute lymphoblastic leukemia. Alexander BM, Wechsler D, Braun TM, Levine J, Herman J, Yanik G, Hutchinson R, Pierce LJ. Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1191-6. PubMed ID: 15978741 [Abstract] [Full Text] [Related]
35. Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia. Klingebiel T, Lang P, Schumm M, Koehl U, Bader P, Schwabe D, Schlegel PG, Eyrich M, Greil J, Beck JF, Niethammer D, Handgretinger R. Pathol Biol (Paris); 2005 Apr 15; 53(3):159-61. PubMed ID: 15781375 [No Abstract] [Full Text] [Related]
36. Curability of cancer in childhood and adolescence: acute lymphoblastic leukemia. Mann G, Gadner H. Wien Klin Wochenschr; 2002 Feb 28; 114(4):141-2. PubMed ID: 12060979 [No Abstract] [Full Text] [Related]
37. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia. Takanashi M, Morimoto A, Yagi T, Kuriyama K, Kano G, Imamura T, Hibi S, Todo S, Imashuku S. Haematologica; 2003 Nov 28; 88(11):1238-44. PubMed ID: 14607752 [Abstract] [Full Text] [Related]
38. Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission. Dini G, Valsecchi MG, Micalizzi C, Busca A, Balduzzi A, Arcese W, Cesaro S, Prete A, Rabusin M, Mazzolari E, Di Bartolomeo P, Sacchi N, Pession A, Giorgiani G, Lanino E, Lamparelli T, Favre C, Bosi A, Manzitti C, Galimberti S, Locatelli F. Bone Marrow Transplant; 2003 Aug 28; 32(3):325-31. PubMed ID: 12858206 [Abstract] [Full Text] [Related]
39. [Childhood acute lymphoblastic leukemia in Norway 1992-2000]. Kolmannskog S, Flaegstad T, Helgestad J, Hellebostad M, Zeller B, Glomstein A. Tidsskr Nor Laegeforen; 2007 May 31; 127(11):1493-5. PubMed ID: 17551551 [Abstract] [Full Text] [Related]
40. HLA-identical haematopoietic stem cell transplantation for acute leukaemia in children: less relapse with higher biologically effective dose of TBI. Willemze AJ, Geskus RB, Noordijk EM, Kal HB, Egeler RM, Vossen JM. Bone Marrow Transplant; 2007 Aug 31; 40(4):319-27. PubMed ID: 17572715 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]